These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 33486018)

  • 1. Mechanistic explanation of the (up to) 3 release phases of PLGA microparticles: Monolithic dispersions studied at lower temperatures.
    Tamani F; Bassand C; Hamoudi MC; Siepmann F; Siepmann J
    Int J Pharm; 2021 Mar; 596():120220. PubMed ID: 33486018
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanistic explanation of the (up to) 3 release phases of PLGA microparticles: Diprophylline dispersions.
    Tamani F; Bassand C; Hamoudi MC; Danede F; Willart JF; Siepmann F; Siepmann J
    Int J Pharm; 2019 Dec; 572():118819. PubMed ID: 31726196
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Towards a better understanding of the different release phases from PLGA microparticles: Dexamethasone-loaded systems.
    Gasmi H; Siepmann F; Hamoudi MC; Danede F; Verin J; Willart JF; Siepmann J
    Int J Pharm; 2016 Nov; 514(1):189-199. PubMed ID: 27543353
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Does PLGA microparticle swelling control drug release? New insight based on single particle swelling studies.
    Gasmi H; Danede F; Siepmann J; Siepmann F
    J Control Release; 2015 Sep; 213():120-127. PubMed ID: 26150116
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of the microencapsulation method and peptide loading on poly(lactic acid) and poly(lactic-co-glycolic acid) degradation during in vitro testing.
    Witschi C; Doelker E
    J Control Release; 1998 Feb; 51(2-3):327-41. PubMed ID: 9685930
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Imaging the porous structure in the core of degrading PLGA microparticles: The effect of molecular weight.
    Mylonaki I; Allémann E; Delie F; Jordan O
    J Control Release; 2018 Sep; 286():231-239. PubMed ID: 30071251
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Porous PLGA microparticles prepared with nanosized/micronized sugar particles as porogens.
    Zhang C; Bodmeier R
    Int J Pharm; 2024 Jul; 660():124329. PubMed ID: 38857662
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Unintended potential impact of perfect sink conditions on PLGA degradation in microparticles.
    Klose D; Delplace C; Siepmann J
    Int J Pharm; 2011 Feb; 404(1-2):75-82. PubMed ID: 21056644
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polymer degradation and in vitro release of a model protein from poly(D,L-lactide-co-glycolide) nano- and microparticles.
    Panyam J; Dali MM; Sahoo SK; Ma W; Chakravarthi SS; Amidon GL; Levy RJ; Labhasetwar V
    J Control Release; 2003 Sep; 92(1-2):173-87. PubMed ID: 14499195
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PLGA-based microparticles: elucidation of mechanisms and a new, simple mathematical model quantifying drug release.
    Faisant N; Siepmann J; Benoit JP
    Eur J Pharm Sci; 2002 May; 15(4):355-66. PubMed ID: 11988397
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Often neglected: PLGA/PLA swelling orchestrates drug release: HME implants.
    Bode C; Kranz H; Fivez A; Siepmann F; Siepmann J
    J Control Release; 2019 Jul; 306():97-107. PubMed ID: 31150749
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of particle size, polydispersity and polymer degradation on progesterone release from PLGA microparticles: Experimental and mathematical modeling.
    Busatto C; Pesoa J; Helbling I; Luna J; Estenoz D
    Int J Pharm; 2018 Jan; 536(1):360-369. PubMed ID: 29217474
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparative study of PLGA microparticle properties loaded with micronized, nanosized or dissolved drug.
    Zhang C; Bodmeier R
    Int J Pharm; 2022 Nov; 628():122313. PubMed ID: 36272513
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Brush-like branched biodegradable polyesters, part III. Protein release from microspheres of poly(vinyl alcohol)-graft-poly(D,L-lactic-co-glycolic acid).
    Frauke Pistel K; Breitenbach A; Zange-Volland R; Kissel T
    J Control Release; 2001 May; 73(1):7-20. PubMed ID: 11337055
    [TBL] [Abstract][Full Text] [Related]  

  • 15. How porosity and size affect the drug release mechanisms from PLGA-based microparticles.
    Klose D; Siepmann F; Elkharraz K; Krenzlin S; Siepmann J
    Int J Pharm; 2006 May; 314(2):198-206. PubMed ID: 16504431
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of the size of biodegradable microparticles on drug release: experiment and theory.
    Siepmann J; Faisant N; Akiki J; Richard J; Benoit JP
    J Control Release; 2004 Apr; 96(1):123-34. PubMed ID: 15063035
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Investigation of the factors influencing the release rates of cyclosporin A-loaded micro- and nanoparticles prepared by high-pressure homogenizer.
    Lee WK; Park JY; Yang EH; Suh H; Kim SH; Chung DS; Choi K; Yang CW; Park JS
    J Control Release; 2002 Dec; 84(3):115-23. PubMed ID: 12468215
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Seeing is believing, PLGA microsphere degradation revealed in PLGA microsphere/PVA hydrogel composites.
    Gu B; Sun X; Papadimitrakopoulos F; Burgess DJ
    J Control Release; 2016 Apr; 228():170-178. PubMed ID: 26965956
    [TBL] [Abstract][Full Text] [Related]  

  • 19. rhBMP-2 release from injectable poly(DL-lactic-co-glycolic acid)/calcium-phosphate cement composites.
    Ruhe PQ; Hedberg EL; Padron NT; Spauwen PH; Jansen JA; Mikos AG
    J Bone Joint Surg Am; 2003; 85-A Suppl 3():75-81. PubMed ID: 12925613
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Continuous in-line homogenization process for scale-up production of naltrexone-loaded PLGA microparticles.
    Sharifi F; Otte A; Yoon G; Park K
    J Control Release; 2020 Sep; 325():347-358. PubMed ID: 32645336
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.